UBS Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.7K | Buy |
2,846
+2,140
| +303% | +$3.53K | ﹤0.01% | 7924 |
|
|
2025
Q1 | $939 | Sell |
706
-408
| -37% | -$543 | ﹤0.01% | 8294 |
|
|
2024
Q4 | $2.08K | Buy |
1,114
+634
| +132% | +$1.19K | ﹤0.01% | 7868 |
|
|
2024
Q3 | $373 | Hold |
480
| – | – | ﹤0.01% | 7754 |
|
|
2024
Q2 | $360 | Sell |
480
-25
| -5% | -$19 | ﹤0.01% | 7789 |
|
|
2024
Q1 | $536 | Hold |
505
| – | – | ﹤0.01% | 7323 |
|
|
2023
Q4 | $530 | Sell |
505
-6,163
| -92% | -$6.47K | ﹤0.01% | 7392 |
|
|
2023
Q3 | $7.47K | Buy |
6,668
+5,756
| +631% | +$6.45K | ﹤0.01% | 6091 |
|
|
2023
Q2 | $1.37K | Buy |
912
+587
| +181% | +$883 | ﹤0.01% | 6853 |
|
|
2023
Q1 | $507 | Sell |
325
-45,544
| -99% | -$71K | ﹤0.01% | 7899 |
|
|
2022
Q4 | $29.4K | Buy |
45,869
+12,565
| +38% | +$8.04K | ﹤0.01% | 6089 |
|
|
2022
Q3 | $44K | Buy |
33,304
+8,181
| +33% | +$10.8K | ﹤0.01% | 5402 |
|
|
2022
Q2 | $56K | Sell |
25,123
-463
| -2% | -$1.03K | ﹤0.01% | 4826 |
|
|
2022
Q1 | $158K | Buy |
25,586
+9,934
| +63% | +$61.3K | ﹤0.01% | 4558 |
|
|
2021
Q4 | $197K | Sell |
15,652
-1,338
| -8% | -$16.8K | ﹤0.01% | 4665 |
|
|
2021
Q3 | $1.56M | Buy |
16,990
+6,844
| +67% | +$627K | ﹤0.01% | 2935 |
|
|
2021
Q2 | $537K | Sell |
10,146
-25,670
| -72% | -$1.36M | ﹤0.01% | 3698 |
|
|
2021
Q1 | $1.29M | Buy |
35,816
+25,262
| +239% | +$910K | ﹤0.01% | 3136 |
|
|
2020
Q4 | $293K | Sell |
10,554
-9,817
| -48% | -$273K | ﹤0.01% | 4031 |
|
|
2020
Q3 | $1.02M | Sell |
20,371
-2,584
| -11% | -$129K | ﹤0.01% | 2904 |
|
|
2020
Q2 | $1.06M | Sell |
22,955
-3,119
| -12% | -$144K | ﹤0.01% | 2774 |
|
|
2020
Q1 | $1.19M | Sell |
26,074
-860
| -3% | -$39.2K | ﹤0.01% | 2537 |
|
|
2019
Q4 | $1.51M | Buy |
26,934
+10,179
| +61% | +$571K | ﹤0.01% | 3000 |
|
|
2019
Q3 | $418K | Buy |
16,755
+9,940
| +146% | +$248K | ﹤0.01% | 3859 |
|
|
2019
Q2 | $290K | Buy |
+6,815
| New | +$290K | ﹤0.01% | 3881 |
|